CONMED Corporation
New York Stock ExchangeTotal Valuation
CONMED Corporation carries a market capitalization of 1.48B, placing it among publicly traded companies globally. Its enterprise value stands at 1.78B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.48B |
| Enterprise Value | 1.78B |
Share Statistics
CONMED Corporation currently has 30.14M shares outstanding.
| Shares Outstanding | 30.14M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
CONMED Corporation trades at a trailing price-to-earnings ratio of 17.75. The price-to-sales ratio is 0.73, and the price-to-book ratio stands at 0.95.
| PE Ratio | 17.75 |
| PS Ratio | 0.73 |
| PB Ratio | 0.95 |
| P/TBV Ratio | -3.08 |
| P/FCF Ratio | 6.03 |
| P/OCF Ratio | 6.66 |
Enterprise Valuation
On an enterprise value basis, CONMED Corporation trades at an EV/EBITDA multiple of 9.61 and an EV/FCF ratio of 9.54. The EV/Sales ratio of 1.30 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.17 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.30 |
| EV / EBITDA | 9.61 |
| EV / EBIT | 16.17 |
| EV / FCF | 9.54 |
Financial Position
CONMED Corporation maintains a current ratio of 1.48, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 80.11, indicating elevated leverage, while an interest coverage ratio of 6.21 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.48 |
| Quick Ratio | 0.61 |
| Debt / Equity | 80.11 |
| Debt / EBITDA | 4.49 |
| Interest Coverage | 6.21 |
Financial Efficiency
CONMED Corporation posts a return on equity of 5.53 and a return on invested capital of 3.98.
| Return on Equity (ROE) | 5.53 |
| Return on Assets (ROA) | 2.44 |
| Return on Invested Capital (ROIC) | 3.98 |
| Return on Capital Employed (ROCE) | 4.09 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.68 |
Taxes
Over the trailing twelve months, CONMED Corporation has paid 26.73M in income taxes, reflecting an effective tax rate of 32.12.
| Income Tax | 26.73M |
| Effective Tax Rate | 32.12 |
Stock Price Statistics
CONMED Corporation's stock has declined approximately -8.37823% over the past 52 weeks. The 50-day moving average sits at 45.01, while the 200-day moving average is 40.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | -8.37823% |
| 50-Day Moving Average | 45.01 |
| 200-Day Moving Average | 40.50 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, CONMED Corporation generated 1.37B in revenue and converted that into 56.50M in net income, yielding earnings per share of 1.84. EBITDA reached 185.66M, while operating income came in at 110.32M.
| Revenue | 1.37B |
| Gross Profit | 765.31M |
| Operating Income | 110.32M |
| Pretax Income | 83.23M |
| Net Income | 56.50M |
| EBITDA | 185.66M |
| EBIT | 110.32M |
| Earnings Per Share (EPS) | 1.84 |
Balance Sheet
CONMED Corporation holds 37.33M in cash and equivalents against 834.25M in total debt, resulting in a net debt position of 796.92M. Total book value stands at 1.04B, with working capital of 220.27M providing operational flexibility.
| Cash & Cash Equivalents | 37.33M |
| Total Debt | 834.25M |
| Net Debt | 796.92M |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | 34.55 |
| Working Capital | 220.27M |
Cash Flow
CONMED Corporation produced 150.59M in operating cash flow over the past twelve months. After subtracting -16.12M in capital expenditures, free cash flow totaled 134.46M - equivalent to 4.39 per share.
| Operating Cash Flow | 150.59M |
| Capital Expenditures | -16.12M |
| Free Cash Flow | 134.46M |
| FCF Per Share | 4.39 |
Margins
CONMED Corporation operates with a gross margin of 55.79, reflecting its pricing power and cost economics. The operating margin of 8.04 and net profit margin of 4.12 provide insight into operational efficiency.
| Gross Margin | 55.79 |
| Operating Margin | 8.04 |
| Pretax Margin | 6.07 |
| Profit Margin | 4.12 |
| EBITDA Margin | 13.54 |
Dividends & Yields
The company's payout ratio of 21.91 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.40 |
| Dividend Yield | N/A |
| Payout Ratio | 21.91 |
| Shareholder Yield | 15.17 |
| FCF Yield | 16.59 |
Stock Splits
CONMED Corporation's most recent stock split took place on September 10, 2001 with a 2:3 split ratio.
| Last Split Date | 9/10/2001 |
| Split Ratio | 2:3 |
Scores
CONMED Corporation posts an Altman Z-Score of 3.53, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.53 |